Advertisement

Clinical Research in Cardiology

, Volume 98, Issue 2, pp 80–88 | Cite as

Athlete’s heart or hypertrophic cardiomyopathy?

  • Jörg Lauschke
  • Bernhard Maisch
REVIEW

Abstract

Intensive endurance training is able to cause a distinct pattern of functional and structural changes of the cardiovascular system. In an unknown proportion of athletes a so called “athlete’s heart” develops. There is an overlap between this type of physiologic cardiac hypertrophy and mild forms of hypertrophic cardiomyopathy (HCM), the most common genetic disorder of the cardiovascular system with a prevalence of 0.2%. HCM is caused by mutations in 14 genes coding for sarcomere proteins. In the literature up to 50% of cases of sudden cardiac death (SCD) in younger sportsmen were connected to hypertrophic cardiomyopathy. It is therefore the most common cause of SCD in highly trained young athletes. Because of this data a great interest in distinguishing these two diagnoses exists. Apart from clinical examination and some non-specific ECG-changes, Echocardiography is the method of choice. The athlete’s heart shows an eccentric biventricular hypertrophy with wall thicknesses under 15 mm and a moderately dilated left ventricle (LVEDD up to 58 mm). HCM is commonly characterized by asymmetric left ventricular hypertrophy with a reduced LV-diameter. In up to 70% of cases left ventricular outflow tract obstruction is evident during stress echocardiography. Systolic function is normal in highly trained athletes and the majority of HCM patients as well. There are important differences regarding diastolic filling patterns. Physiological hypertrophy is consistent with a normal diastolic function with even increased early diastolic filling. In case of HCM diastolic dysfunction (mostly relaxation disturbances) occurs in the majority of patients and is therefore inconsistent with an athlete’s heart. If the diagnosis could not be stated using echocardiography, methods like cardiac-MRI, metabolic exercise testing, histological studies of endomyocardial biopsies and genetic testing can provide further information. A correct diagnosis may on the one hand prevent some athletes from sudden cardiac death. On the other hand sportsmen with an athlete’s heart are reassured and able to continue as competitors. New insights into electrophysiological changes during physiological hypertrophy could probably change this view.

Keywords

athlete’s heart hypertrophic cardiomyopathy sudden cardiac death athlete 

References

  1. 1.
    Basavarajaiah S, Wilson M, Junagde S et al (2006) Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma. Br J Sports Med 40:727–729PubMedCrossRefGoogle Scholar
  2. 2.
    Corrado D, Basso C, Rizzoli G et al (2003) Does sport activity enhance the risk of sudden cardiac death in adolescents and young adults? J Am Coll Cardiol 42:1959–1963PubMedCrossRefGoogle Scholar
  3. 3.
    D’Andrea A, Caso P, Cuomo S et al (2006) Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes. Br J Sports Med 40:244–250PubMedCrossRefGoogle Scholar
  4. 4.
    Dickhuth HH, Hipp A, Niess A et al (2001) Differenzialdiagnostik der physiologischen Herzhypertrophie (Sportherz). Dtsch Z Sportmed 6:205–210Google Scholar
  5. 5.
    Dickhuth HH, Lehmann M, Auch-Schwelk W et al (1987) Physical training, vegetative regulation and cardiac hypertrophy. J Cardiovasc Pharmacol 10(Suppl 6):71–78Google Scholar
  6. 6.
    Dickhuth HH, Röcker K, Mayer F et al (2004) Ausdauersport und kardiale Adaptation (Sportherz). Herz 29:373–380PubMedCrossRefGoogle Scholar
  7. 7.
    Dickhuth HH, Röcker K, Niess A et al (1996) The echocardiographic determination of volume and muscle mass of the heart. Int J Sports Med 17(Suppl 3):132–139CrossRefGoogle Scholar
  8. 8.
    Durakovic Z, Misigoj-Durakovic M, Medved R et al (2002) Sudden death due to physical exercise in the elderly. Coll Antropol 26:239–243PubMedGoogle Scholar
  9. 9.
    Elliott PM, Gimeno JR, Tomé MT et al (2006) Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27:1933–1941PubMedCrossRefGoogle Scholar
  10. 10.
    Firoozi S, Sharma S, McKenna WJ (2003) Risk of competitive sport in young athletes with heart disease. Heart 89:710–714PubMedCrossRefGoogle Scholar
  11. 11.
    Hart G (2003) Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes? Exp Physiol 88:639–644PubMedCrossRefGoogle Scholar
  12. 12.
    Kohl H, Powell K, Gordon N et al (1992) Physical activity, physical fitness and sudden cardiac death. Epidemiol Rev 14:37–58PubMedGoogle Scholar
  13. 13.
    Lie H, Mundal R, Erikssen J (1985) Coronary risk factors and incidence of coronary death in relation to physical fitness: seven-year-follow-up study of middle aged and elderly men. Eur Heart J 6:147–157PubMedGoogle Scholar
  14. 14.
    Maron BJ (1986) Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 7:190–203. (abstract)PubMedGoogle Scholar
  15. 15.
    Maron BJ, Anan TJ, Roberts WC (1981) Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Ciculation 63:882–894PubMedGoogle Scholar
  16. 16.
    Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Circulation 92:785–789PubMedGoogle Scholar
  17. 17.
    Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a widw angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 48:418–428PubMedCrossRefGoogle Scholar
  18. 18.
    Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes. Circulation 91:1596–1601PubMedGoogle Scholar
  19. 19.
    Maron BJ, Roberts WC (1979) Quantitative analysis of cardic muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59:689–706PubMedGoogle Scholar
  20. 20.
    Maron BJ, Wolfson JK, Epstein SE et al (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545–557PubMedCrossRefGoogle Scholar
  21. 21.
    Maron MS, Olivotto I, Zenovich et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232–2239PubMedCrossRefGoogle Scholar
  22. 22.
    Marti B, Goerre S, Spuhler T et al (1989) Plötzliche Todesfälle an Schweizer Volksläufen 1978–1987: eine epidemiologisch-pathologische Studie. Schweiz Med Wochenschr 119:473–482PubMedGoogle Scholar
  23. 23.
    Meyer K, Greinacher W, Weidemann H (1991) Koronarpatienten im Fitness-Studio–eine riskante Bewegungstherapie. Dtsch Z Sportmed 42:60–66Google Scholar
  24. 24.
    Nistri S, Olivotto I, Atocchi S et al (2006) Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian registry for hypertrophic cardiomyopathy). Am J Cardiol 98:960–965PubMedCrossRefGoogle Scholar
  25. 25.
    Paulus WJ, Tschöpe C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European Society of Cardiology. Eur Heart J 28:2539–2550CrossRefGoogle Scholar
  26. 26.
    Pelliccia A, Culasso F, Di Paolo FM, Maron BJ (1999) Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 130:23–31PubMedGoogle Scholar
  27. 27.
    Pluim BM, Zwinderman AH, Van der Laarse A et al (1999) The athlete’s heart: a meta-analysis of cardiac structure and function. Circulation 100:336–344Google Scholar
  28. 28.
    Scharhag J, Schneider G, Urhausen A et al (2002) Athlete’s heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 10:1856–1863CrossRefGoogle Scholar
  29. 29.
    Scheffold T, Binner P, Erdmann J et al (2005) Hypertrophe Kardiomyopathie. Herz 30:550–557PubMedCrossRefGoogle Scholar
  30. 30.
    Schmidt-Trucksäss A, Schmid A, Häussler C et al (2001) Left ventricular wall motion during diastolic filling in endurance-trained athletes. Med Sci Sports Exerc 33(2):189–195PubMedGoogle Scholar
  31. 31.
    Shah PM, Gramiak R, Kramer DH (1969) Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 40:3–11PubMedGoogle Scholar
  32. 32.
    Scharhag J, Urhausen A, Schneider G et al (2003) Left ventricular mass in endurance-athletes with athlete′s heart and untrained subjects–comparison between different echocardiographic methods and MRI. Z Kardiol 92:309–318PubMedCrossRefGoogle Scholar
  33. 33.
    Sharma S, Elliott PM, Whyte G et al (2000) Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 36:864–870PubMedCrossRefGoogle Scholar
  34. 34.
    Sherrid MV, Mahenthiran J, Casteneda V et al (2006) Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy. Am J Cardiol 97:106–112CrossRefGoogle Scholar
  35. 35.
    St. John Sutton MG, Lie JT, Anderson KR et al (1980) Histopathological specifity of hypertrophic obstructive cardiomyopathy. Br Heart J 44:433–443PubMedCrossRefGoogle Scholar
  36. 36.
    Van Driest SL, Ommen SR, Tajik AJ et al (2005) Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 80:463–469PubMedCrossRefGoogle Scholar
  37. 37.
    Wight JN Jr, Salem D (1995) Sudden cardiac death and the “athlete's heart”. Arch Int Med 14 (abstract)Google Scholar
  38. 38.
    Wigle ED, Sasson Z, Henderson MA et al (1985) Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review. Prog Cardiovsc Dis 28:1–83CrossRefGoogle Scholar
  39. 39.
    Wigle ED (2001) The diagnosis of hypertrophic cardiomyopathy. Heart 86:709–714PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2008

Authors and Affiliations

  1. 1.Department of Internal Medicine and CardiologyPhilipps-Universität MarburgMarburgGermany
  2. 2.Department of Internal Medicine and CardiologyUniversity Hospital Giessen and Marburg, GmbHMarburgGermany

Personalised recommendations